ChartMill assigns a Buy % Consensus number of 85% to IMAB. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-24 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-17 | BTIG | Maintains | Buy -> Buy |
| 2025-10-03 | Leerink Partners | Initiate | Outperform |
| 2025-09-10 | BTIG | Reiterate | Buy -> Buy |
| 2025-09-09 | BTIG | Initiate | Buy |
| 2025-09-08 | Needham | Reiterate | Buy -> Buy |
| 2025-08-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-20 | Needham | Maintains | Buy -> Buy |
| 2025-07-09 | Needham | Reiterate | Buy -> Buy |
| 2025-07-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-27 | Needham | Maintains | Buy -> Buy |
| 2025-04-04 | Needham | Reiterate | Buy -> Buy |
| 2025-04-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-12 | Needham | Reiterate | Buy -> Buy |
| 2024-03-18 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-15 | Needham | Maintains | Buy -> Buy |
| 2024-02-08 | Needham | Maintains | Buy -> Buy |
| 2023-09-25 | Needham | Maintains | Buy -> Buy |
| 2023-09-05 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-18 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-18 | Needham | Reiterate | Buy -> Buy |
| 2023-08-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-05 | Needham | Reiterate | Buy -> Buy |
| 2023-04-19 | Needham | Reiterate | Buy |
| 2023-04-03 | Needham | Maintains | Buy |
| 2023-04-03 | Piper Sandler | Maintains | Overweight |
12 analysts have analysed IMAB and the average price target is 8.5 USD. This implies a price increase of 83.58% is expected in the next year compared to the current price of 4.63.
The consensus rating for I-MAB-SPONSORED ADR (IMAB) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering I-MAB-SPONSORED ADR (IMAB) is 12.